IP Library Granted Patent US 10,253,358
Granted Patent B2
US 10,253,358 · App. 15/033,803 · Granted Apr 9, 2019

Multiple-control calibrators for DNA quantitation

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,253,358
App. No.
15/033,803
Granted
Apr 9, 2019
Kind
B2
Abstract

The present invention provides DNA plasmids that find use as calibrators or reference standards for calculating DNA quantities in a sample. In particular, provided herein are DNA plasmids that contain multiple control fragments, and methods of their use in DNA quantitation.

Claims (14)

1. A calibrator DNA comprising:

(a) a vector portion, and

(b) a control portion;

wherein the control portion comprises three or more linked control fragments separated by restriction endonuclease recognition sites, wherein each of said three or more control fragments comprises a sequence corresponding to a portion of a human gene, or comprises a sequence corresponding to a portion of a human gene in which residues corresponding to non-methylated C residues in that human gene are replaced with T residues, and wherein residues corresponding to methylated C residues in the human gene are replaced with C residues,

wherein the three or more control fragments comprise sequences corresponding to portions of the human ACTB, NDRG4, and BMP3 genes, wherein residues corresponding to non-methylated C residues in the human ACTB, NDRG4, and/or BMP3 genes are replaced with T residues, and wherein residues corresponding to methylated C residues in the human ACTB, NDRG4, and BMP3 genes are replaced with C residues,

wherein the vector portion circularizes the calibrator DNA by flanking both ends of the control portion,

and wherein the vector portion and the control portion are separated by restriction endonuclease recognition sites; and wherein the restriction endonuclease recognition sites that separate the vector portion from the control portion, and each of the linked control fragments from each other are recognition sites for the same restriction endonuclease.

2. The calibrator DNA of claim 1 , wherein the control portion is between 50 and 2000 nucleotides in length.

3. The calibrator DNA of claim 2 , wherein the control portion is between 200 and 600 nucleotides in length.

4. The calibrator DNA of claim 1 , wherein each control fragment is between 10 and 500 nucleotides in length.

5. The calibrator DNA of claim 4 , wherein each control fragment is between 50 and 200 nucleotides in length.

6. The calibrator DNA of claim 1 , wherein the control portion further comprises one or more of the control fragments comprising a sequence corresponding to a portion of the human KRAS gene.

7. The calibrator DNA of claim 6 , wherein one control fragment comprises a sequence corresponding to a portion of the human KRAS gene having a 38A mutation.

8. The calibrator DNA of claim 6 , wherein one control fragment comprises a sequence corresponding to a portion of the human KRAS gene having a 35C. mutation.

Assignments (4)
PATENT SECURITY AGREEMENT Recorded Jan 14, 2025
From: EXACT SCIENCES CORPORATION
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 069898/0249 →
MERGER Recorded Jan 14, 2022
From: EXACT SCIENCES DEVELOPMENT COMPANY, LLC
To: EXACT SCIENCES CORPORATION
Reel/Frame 058738/0465 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 4, 2017
From: EXACT SCIENCE CORPORATION
To: EXACT SCIENCES DEVELOPMENT COMPANY, LLC
Reel/Frame 043778/0548 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 6, 2016
From: DOMANICO, MICHAEL; TYLER, ILSE A.; AIZENSTEIN, BRIAN; ALLAWI, HATIM; LIDGARD, GRAHAM P.
To: EXACT SCIENCES CORPORATION
Reel/Frame 038484/0337 →